Small human studies suggest that kudzu may reduce short-term alcohol intake, but limited evidence leaves its role in treating ...

The research team estimated that, between 1990 and 2023, the number of cancer deaths attributed to alcohol more than doubled from 11,361 to 23,126. After accounting for population size and age, the ...

Patients with AIS-LVO and large ischemic cores identified at primary stroke centers before transfer benefit more with add-on ...

Diagnosis of T1D in adults is a major focus of the 2026 consensus report from the American Diabetes Association and the European Association for the Study of Diabetes.

In patients with severe fibromyalgia, rozanolixizumab may reduce the impact of the condition on health and function but may ...

A regulator-mandated, Novo Nordisk-funded study finds no increased risk for pancreatic cancer with semaglutide vs other ...

As GLP-1 receptor agonists and dual incretin agents become more common in treating obesity and type 2 diabetes, primary care ...

Patients with idiopathic pulmonary fibrosis who train by cycling one leg at a time during rehabilitation gain more exercise ...

The agency’s backing could potentially increase the use of this first-to-be-approved nonsurgical PDT option in treating basal ...

This marks the third ccRCC approval for the hypoxia-inducible factor-2-alpha inhibitor belzutifan. Its previous approvals ...

Nitasha Sarswat, MD, hopes emerging ATTR-CM data will reshape how clinicians identify, monitor, and personalize care for ...

It looks like me, but the voice wasn’t me.’ New Orleans doctor can’t shut down fake look-a-like video hawking supplements.